FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37992311000001105: Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jan 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
656691000001115 Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
656701000001115 Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Ceritinib 150mg tablets true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Zykadia true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Ceritinib true Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 4 x 21 tablets Has AMP True Zykadia 150mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start